Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
Gut
|
April 28, 2022
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Simeng Lin, Louis Hs Lau, Neil Chanchlani, et al.
Journal of Crohn'S & Colitis
|
December 21, 2025
Clinical utility of pre-treatment 4-digit resolution HLA genotyping to guide anti-TNF choice and concomitant immunomodulator use
Phoebe Hodges, Christopher Roberts, Miles Parkes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
August 27, 2011
Esophageal adenocarcinoma and hypertrophic osteoarthropathy with improvement following resection of esophageal cancer
Mihir D Wechalekar, Nicholas A Kennedy, Michael Ahern, et al.
The Lancet. Gastroenterology & Hepatology
|
June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply
James L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Expert Review of Gastroenterology & Hepatology
|
December 16, 2014
Predicting outcomes in acute severe ulcerative colitis
Nicholas T Ventham, Rahul Kalla, Nicholas A Kennedy, et al.
Scientific Reports
|
November 7, 2022
Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK
Rhona C F Sinclair, Sean Nadaraja, Nicholas A Kennedy, et al.
International Journal of Clinical Pharmacy
|
April 3, 2023
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
Nicholas A Kennedy, Maureen M Achebe, Patrick Biggar, et al.
British Journal of Clinical Pharmacology
|
November 14, 2020
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis
Benedikt Schaefer, Moritz Tobiasch, André Viveiros, et al.
World Journal of Gastrointestinal Endoscopy
|
October 6, 2017
Colonoscopy quality with Entonox<sup>®</sup><i>vs</i> intravenous conscious sedation: 18608 colonoscopy retrospective study
Alexander R Robertson, Nicholas A Kennedy, James A Robertson, et al.
Gastroenterology
|
September 19, 2015
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
Joana Torres, Ray K Boyapati, Nicholas A Kennedy, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
Gut
|
April 28, 2022
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
Simeng Lin, Louis Hs Lau, Neil Chanchlani, et al.
Journal of Crohn'S & Colitis
|
December 21, 2025
Clinical utility of pre-treatment 4-digit resolution HLA genotyping to guide anti-TNF choice and concomitant immunomodulator use
Phoebe Hodges, Christopher Roberts, Miles Parkes, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
August 27, 2011
Esophageal adenocarcinoma and hypertrophic osteoarthropathy with improvement following resection of esophageal cancer
Mihir D Wechalekar, Nicholas A Kennedy, Michael Ahern, et al.
The Lancet. Gastroenterology & Hepatology
|
June 13, 2021
SARS-CoV-2 vaccination for patients with inflammatory bowel disease - Authors' reply
James L Alexander, Nicholas A Kennedy, Charlie W Lees, et al.
Expert Review of Gastroenterology & Hepatology
|
December 16, 2014
Predicting outcomes in acute severe ulcerative colitis
Nicholas T Ventham, Rahul Kalla, Nicholas A Kennedy, et al.
Scientific Reports
|
November 7, 2022
Real-world experience of intravenous ferric derisomaltose evaluated through safety and efficacy reporting in the UK
Rhona C F Sinclair, Sean Nadaraja, Nicholas A Kennedy, et al.
International Journal of Clinical Pharmacy
|
April 3, 2023
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
Nicholas A Kennedy, Maureen M Achebe, Patrick Biggar, et al.
British Journal of Clinical Pharmacology
|
November 14, 2020
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis
Benedikt Schaefer, Moritz Tobiasch, André Viveiros, et al.
World Journal of Gastrointestinal Endoscopy
|
October 6, 2017
Colonoscopy quality with Entonox<sup>®</sup><i>vs</i> intravenous conscious sedation: 18608 colonoscopy retrospective study
Alexander R Robertson, Nicholas A Kennedy, James A Robertson, et al.
Gastroenterology
|
September 19, 2015
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
Joana Torres, Ray K Boyapati, Nicholas A Kennedy, et al.
Page
of 12